Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Electronic component and a system and method for producing an electronic component
Display screen or portion thereof with animated graphical user interface
Dynamically reconfigurable systolic array accelorators
Dental fillers including a phosphorus containing surface treatment, and compositions and methods thereof
Manufacturing process for cellular screening substratum, resultant substratum, and method and apparatus for screening
Pressing mold for optical lenses and method for manufacturing glass optical lenses
Crystalline solvates of 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride
  Randomly Featured Patents
Dyed antistain nylon with cationic dye modifier
Connector for lateral cable of tire chains
Disperse mono-azo dye mixture for dyeing synthetic textiles
Color toner for developing electrostatic image comprising a polyalkylene having a crystallinity of 10-50%
Aerosol container and dispenser machine
Picture viewer
Battery module
Fault detection apparatus for a programmable controller
Communication device
Tool bit with marking member